BCART.BR
Price:
$0.29
Market Cap:
$27.24M
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. Its proprietary molecular diagnostics Idylla platform is a real-time polymerase chain reaction system that offers molecular information that allows treatment selection and treatment progress monitoring. The company offers Idylla BRAF, KRAS, MSI, EGFR, and NRAS-BRAF mutation tests; and Idylla SARS-CoV-2/Flu/RSV panels and SARS-CoV-2 tests, as well as SeptiCyte RAPID, a rapid host-response test. It also provides research products, including MSI, KRAS, BRAF, ctEGFR, NRAS-BRAF-EGFR S492R, ...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2015-04-27
Stock Exchange
EURONEXT
Ticker
BCART.BR
According to Biocartis Group NV’s latest financial reports and current stock price. The company's current PE Ratio is -0.32. This represents a change of -40.87% compared to the average of -0.54 of the last 4 quarters.
The mean historical PE Ratio of Biocartis Group NV over the last ten years is -15.06. The current -0.32 PE Ratio has changed 112.45% with respect to the historical average. Over the past ten years (40 quarters), BCART.BR's PE Ratio was at its highest in in the December 2019 quarter at 0. The PE Ratio was at its lowest in in the January 2013 quarter at -19.16.
Average
-15.06
Median
-11.23
Minimum
-67.62
Maximum
-0.49
Discovering the peaks and valleys of Biocartis Group NV PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 290.66%
Maximum Annual PE Ratio = -0.49
Minimum Annual Increase = -85.35%
Minimum Annual PE Ratio = -67.62
Year | PE Ratio | Change |
---|---|---|
2022 | -0.49 | -85.35% |
2021 | -3.34 | -30.41% |
2020 | -4.80 | -16.45% |
2019 | -5.74 | -52.60% |
2018 | -12.11 | -18.60% |
2017 | -14.88 | 43.60% |
2016 | -10.36 | -25.93% |
2015 | -13.99 | -79.32% |
2014 | -67.62 | 290.66% |
2013 | -17.31 | 24.74% |
The current PE Ratio of Biocartis Group NV (BCART.BR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.87
5-year avg
-5.29
10-year avg
-15.06
Biocartis Group NV’s PE Ratio is less than Mithra Pharmaceuticals SA (-0.09), greater than MDxHealth SA (-17.59), less than Ontex Group NV (10.83), greater than argenx SE (-157.17), greater than Celyad Oncology SA (-0.81),
Company | PE Ratio | Market cap |
---|---|---|
-0.09 | $14.93M | |
-17.59 | $85.63M | |
10.83 | $709.23M | |
-157.17 | $29.16B | |
-0.81 | $9.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biocartis Group NV using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biocartis Group NV or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Biocartis Group NV's PE Ratio?
How is the PE Ratio calculated for Biocartis Group NV (BCART.BR)?
What is the highest PE Ratio for Biocartis Group NV (BCART.BR)?
What is the 3-year average PE Ratio for Biocartis Group NV (BCART.BR)?
What is the 5-year average PE Ratio for Biocartis Group NV (BCART.BR)?
How does the current PE Ratio for Biocartis Group NV (BCART.BR) compare to its historical average?